Mutations in ABHD12 Cause the Neurodegenerative Disease PHARC: An Inborn Error of Endocannabinoid Metabolism
- 1 September 2010
- journal article
- research article
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 87 (3) , 410-417
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Monoacylglycerol Lipase Limits the Duration of Endocannabinoid-Mediated Depolarization-Induced Suppression of Excitation in Autaptic Hippocampal NeuronsMolecular Pharmacology, 2009
- Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic PainThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Biology of endocannabinoid synthesis systemProstaglandins & Other Lipid Mediators, 2009
- Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effectsNature Chemical Biology, 2008
- 2‐Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal‐cannabidiol‐sensitive receptors on microglial cellsGlia, 2008
- Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 ElevationJournal of Biological Chemistry, 2008
- A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-ArachidonoylglycerolChemistry & Biology, 2007
- Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial CellsJournal of Neuroscience, 2007
- Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampusNature Neuroscience, 2005
- An endogenous cannabinoid (2-AG) is neuroprotective after brain injuryNature, 2001